Evoke Pharma, Inc.

Historical 13F Holders

Symbol
EVOK
CUSIP
30049G203
All holders as of
Q2 2024
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 30049G203 since 12/18/2024, largest first.

Filer % of Class Filed
Nantahala Capital Management, LLC 13D/A
16.0% 2/3/2025
Event 2/3/2025
Bleichroeder LP 13G/A
10.0% 3/24/2025
Event 3/24/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2024 Q2 17 3.15 M $1.67M
2024 Q1 16 3.16 M $1.93M
2023 Q4 12 68.4 k $71.8k
2023 Q3 12 67.2 k $92.4k
2023 Q2 12 59.2 k $97.4k
2023 Q1 13 68.9 k $131k
2022 Q4 14 60.9 k $161k
2022 Q3 12 62.6 k $117k
2022 Q2 14 70.5 k $228k